Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from NYSE

Clearwater Paper (NYSE:CLW) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Benzinga

Amazon Q1 Takeaways: Mixed Earnings, Lower Guidance Sends Stock Falling

Amazon.com Inc (NASDAQ: AMZN) reported first-quarter financial results after market close Thursday. Here are the key highlights for investors.

Benzinga

SM Energy: Q1 Earnings Insights

SM Energy (NYSE:SM) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings SM Energy beat estimated earnings by 17.16%, reporting an EPS of $1.98 versus an estimate of $1.69.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Recap: L3Harris Technologies Q1 Earnings

L3Harris Technologies (NYSE:LHX) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:30 PM. Here's what investors need to know about the announcement.

Benzinga

Recap: Evertec Q1 Earnings

Evertec (NYSE:EVTC) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Evertec beat estimated earnings by 12.9%, reporting an EPS of $0.7 versus an estimate of $0.62.

Benzinga

Peering Into Affiliated Managers Group Inc's Recent Short Interest

Affiliated Managers Group Inc's (NYSE:AMG) short percent of float has fallen 24.74% since its last report. The company recently reported that it has 573.50 thousand shares sold short, which is 1.46% of all regular shares that are available for trading.

Benzinga

Markets Surge Despite Drop In US GDP

U.S. indices traded higher Thursday despite a drop in U.S. GDP. Strength in stocks is possibly due to better-than-expected quarterly earnings from multiple companies as well as a rebound following a selloff earlier in the week.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Here's Why Bread Financial Shares Are Up Post Q1

Bread Financial Holdings, Inc (NYSE:BFH) reported first-quarter FY22 revenue (total net interest and non-interest income) growth of 15% year-on-year to $921 million missing the consensus of $936.4 million. Higher average loan balances, improved loan yields, and improvement in the cost of funds drove the growth. Credit sales increased 14% Y/Y to $6.9 billion…

Benzinga

Iron Mountain Registers 15% Revenue Growth In Q1

Iron Mountain Inc (NYSE:IRM) reported first-quarter FY22 revenue growth of 15% year-on-year to $1.248 billion, marginally beating the consensus of $1.240 billion. Storage Rental Revenue grew 6% Y/Y to $751 million. Service Revenue rose 33% Y/Y to $497 million. Global RIM business revenue increased 7.9% Y/Y. Global Data Center business revenue increased 36.4%…

Benzinga

All The Stocks Bill Hwang's Archegos Capital Is Accused Of Manipulating

From March 2020 through its collapse in March 2021, Archegos Capital Management, headed by Sung Kook (Bill) Hwang and partners, entered into a manipulative scheme that increased Archego’s bottom line from around $4 billion to $36 billion, according to a SEC lawsui

Benzinga

Why ASE Technology Shares Are Rising Today

ASE Technology Holding Co, Ltd (NYSE:ASX) reported first-quarter FY22 revenue growth of 21% year-on-year to NT$144.4 billion ($5.16 billion), beating the consensus of $4.97 billion. ATM net revenues were NT$84 billion, down by 9% Q/Q, EMS net revenues were NT$61.2 billion, down by 25% Q/Q. Net Revenues from Packaging rose 15.8% Y/Y to…

Benzinga

Stocks That Hit 52-Week Lows On Thursday

During Thursday, 849 stocks hit new 52-week lows.

Benzinga

Analyst Slash Earnings Estimates For Alibaba, Baidu, Others Again Amid Surging Covid Environment

Analysts slashed the earnings estimates for the Chinese technology giants for a second straight month amid the nation’s persistent goal of its Covid-Zero strategy, Bloomberg reports. Analysts trimmed Alibaba Group Holding Limited (NYSE:BABA) estimates by 4.2% and Baidu, Inc (NASDAQ:BIDU) by 8.1%. U.S.-listed shares of Baidu have lost 10% in April, while those of Alibaba…

Benzinga

Volta Partners With Michigan OFME, DTE Energy On Improving EV Charging Infrastructure

Volta Inc (NYSE:VLTA) revealed its paid partnership with the Michigan Office of Future Mobility and Electrification (OFME) and DTE Energy Co (NYSE:DTE). Michigan's OFME and DTE will fund the use of Volta's PredictEV software product to identify locations within underserved areas. PredictEV analyzes disparate data sources, including local mobility, demographic, commercial, and site-specific data, to…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What Elon Musk's Twitter Deal Says About His Wealth

Elon Musk has finalized a deal to buy social media platform Twitter, Inc. (NYSE: TWTR) with a financing plan that includes commitments from bankers and himself.

Benzinga

Smith & Nephew Posts Q1 Sales Growth As Elective Procedures Rebound

Smith & Nephew PLC (NYSE:SNN) posted Q1 revenue of $1.31 billion, up 3.3% on a reported basis (including -2.6% currency effect) and up 5.9% on an underlying basis. Sports Medicine & ENT revenue up 8.6% underlying. Advanced Wound Management revenue up 8.0% underlying and Orthopedics revenue up 2.6% underlying Established Markets revenue…

Benzinga

Recap: Applied Industrial Q3 Earnings

Applied Industrial (NYSE:AIT) reported its Q3 earnings results on Thursday, April 28, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: DTE Energy Q1 Earnings

DTE Energy (NYSE:DTE) reported its Q1 earnings results on Thursday, April 28, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Northrop Grumman's Q1 Bottom-Line Beats Street View; Reaffirms FY22 Guidance

Northrop Grumman Corp (NYSE:NOC) reported a first-quarter FY22 sales decline of 4% year-over-year to $8.79 billion, -2% on an organic basis, missing the consensus of $8.88 billion. Sales by segments: Aeronautics Systems $2.7 billion (-10% Y/Y), Defense Systems $1.28 billion (-18% Y/Y), Mission Systems $2.49 billion (-4% Y/Y), and Space Systems $2.86…

Benzinga

What 4 Analyst Ratings Have To Say About IDEX

IDEX (NYSE:IEX) has observed the following analyst ratings within the last quarter:

Benzinga

Here's How Much You Would Have Made Owning Salesforce Stock In The Last 15 Years

Salesforce (NYSE:CRM) has outperformed the market over the past 15 years by 13.74% on an annualized basis producing an average annual return of 20.94%. Currently, Salesforce has a market capitalization of $184.57 billion.

Benzinga

Here's How Much You Would Have Made Owning Mastercard Stock In The Last 10 Years

Mastercard (NYSE:MA) has outperformed the market over the past 10 years by 11.94% on an annualized basis producing an average annual return of 23.75%. Currently, Mastercard has a market capitalization of $371.60 billion.

Benzinga

Textron Shares Soar On Q1 Earnings Beat

Textron Inc. (NYSE:TXT) reported first-quarter FY22 sales growth of 4.2% year-over-year to $3 billion, beating the consensus of $2.74 billion. Revenue by segments: Textron Aviation $1.04 billion (+20.2% Y/Y), Bell $834 million (-1.4% Y/Y), Textron Systems $273 million (-16.8% Y/Y) and Industrial $838 million (+1.6% Y/Y). EPS of $0.88 topped the consensus…

Benzinga

PulteGroup Stock Gains On Q1 Beat, Registers 18% Home Sale Revenue Growth

PulteGroup Inc (NYSE:PHM) reported first-quarter FY22 total revenue growth of 16.8% year-over-year to $3.19 billion, beating the consensus of $3.07 billion. Home sale revenues $3.1 billion (+18%) and Financial Services revenue $84.14 million (-20.7% Y/Y). Home sales revenues were driven by an 18% Y/Y increase in average sales price to $508,000, as…

Benzinga

FDA Gives Green Signal To Pfizer's Duchenne Gene Therapy Trial

After the FDA lifted its hold on a late-stage study, Pfizer Inc (NYSE:PFE) said it would open the first U.S. trial sites for its experimental gene therapy for a muscle-wasting disorder. The FDA had put Pfizer's Investigational New Drug (IND) application for fordadistrogene movaparvovec on hold, and Pfizer has addressed the agency's requests related…

1 … 346 347 348 349

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.